Most plaintiff privacy firms are, at their core, economic enterprises. They pursue cases where the combination of legal merit, class size, and damages structure produces a return on litigation investment. That calculus is not cynical — it is the mechanism through which private enforcement of privacy law functions, and it has produced billions of dollars in accountability for companies that violated consumer privacy at scale.
Clarkson Law Firm, P.C. operates from a different starting point.
Founded by Ryan Clarkson and headquartered in Los Angeles — with offices in Malibu — the firm’s stated mission is to “create a more fair, equitable, and sustainable society through mass actions and public interest litigation.” That language could be marketing copy at many firms. At Clarkson, it describes an actual strategic orientation that shapes which cases are taken, which defendants are targeted, which legal theories are pursued, and what outcomes are sought beyond financial settlements.
In the data privacy space, this public interest orientation has produced a focused, technically sophisticated practice centered on the cases where the harm from privacy violations is most concrete, most emotionally resonant, and most clearly connected to the kind of institutional conduct that litigation should address: healthcare providers deploying advertising tracking technologies on patient-facing portals; fertility clinics transmitting reproductive health information to social media advertising infrastructure; health information platforms monetizing users’ most sensitive medical searches; and — at the emerging frontier — AI systems in healthcare collecting patient data for training purposes without meaningful consent.
This is not a firm optimizing for volume of filings or speed to settlement. It is a firm selecting cases for their capacity to drive genuine behavioral change at the intersection of healthcare, technology, and patient privacy. And for healthcare organizations that have not addressed their tracking technology compliance, that orientation makes Clarkson Law Firm a particularly consequential adversary.
The Firm: Public Interest Mission Meets Technical Privacy Sophistication
Ryan Clarkson and the Firm’s Identity
Ryan Clarkson founded Clarkson Law Firm with an explicit commitment to using mass litigation as a mechanism for social change — not merely for generating plaintiff recoveries. This commitment is reflected in the firm’s practice areas, which extend beyond data privacy into environmental law, consumer protection, and AI ethics. The common thread is the use of class action and mass tort mechanisms to address large-scale institutional harms that individual plaintiffs cannot effectively remedy on their own.
In the privacy space, this orientation produces a distinctive case selection approach. Clarkson Law Firm does not pursue the full universe of technically available CIPA claims against any company running pixels without consent. It pursues the cases where the harm is most real, the population most vulnerable, and the potential for institutional change most significant. Healthcare pixel cases — and specifically, fertility clinic and patient portal cases — fit this profile precisely.
The firm’s Los Angeles base and Malibu offices are not merely geographic facts. They situate Clarkson in the Southern California healthcare and technology ecosystem, giving the firm proximity to the major hospital systems, regional health networks, fertility clinics, and digital health companies that are its primary targets — and to the California courts where CIPA and CMIA claims are litigated.
The Public Interest Model and What It Means for Defendants
The distinction between a profit-optimizing plaintiff firm and a public-interest-oriented plaintiff firm matters for how defendants should assess and respond to Clarkson litigation.
A purely economic plaintiff firm negotiates settlements primarily around financial compensation — the settlement fund, the class recovery, the attorney fees. A public-interest plaintiff firm negotiates settlements with additional emphasis on injunctive relief and behavioral change — what the defendant commits to do differently going forward, what compliance infrastructure it implements, what oversight mechanisms ensure it stays compliant.
For healthcare defendants, this means that settling with Clarkson is not simply a matter of writing a check and moving on. It is likely to involve commitments to remediate tracking technology configurations, implement specific compliance processes, and submit to some form of monitoring or reporting. These structural settlement components — while often less financially dramatic than the monetary payment — represent a more fundamental and lasting form of accountability.
For compliance teams, the public interest orientation is actually a useful signal: if your organization’s practices are the kind that Clarkson Law Firm specifically targets, the path to resolving the risk is not merely adequate financial reserves. It is genuine compliance remediation of the kind that would satisfy a plaintiff firm whose goal is changing behavior, not just extracting money.
The Multi-Practice Context: Environmental, AI, and Consumer Protection
Clarkson Law Firm’s practice spans data privacy, environmental law, consumer protection, and AI ethics. This breadth is not accidental — it reflects a coherent philosophy about how different areas of law can be used to address systemic corporate harms that affect large populations.
For compliance professionals, the multi-practice context matters because it signals that Clarkson is not merely following the current plaintiff litigation trend. When healthcare pixel cases eventually run their course as a primary litigation vehicle — as regulatory compliance improves and the pool of non-compliant defendants shrinks — Clarkson will not disappear from the healthcare privacy space. It will move to the next frontier, which the firm has already identified: AI and automated decision-making in healthcare.
Understanding the firm’s full practice scope helps compliance teams anticipate not just the current threat profile but the emerging one.
The Core Legal Framework: CIPA, ECPA, and Their Healthcare Application
CIPA Section 631 in the Patient Portal Context
The California Invasion of Privacy Act Section 631 wiretapping theory applies to healthcare pixel cases with particular force because of a specific characteristic of healthcare website architecture that does not exist in other digital contexts: the URL structure of healthcare websites is inherently diagnostic.
In a typical e-commerce CIPA case, the URL of a page visited — retailer.com/products/running-shoes — may reveal consumer preferences but not sensitive personal information. In a healthcare context, the URL of a page visited — hospitalname.com/services/oncology/chemotherapy-side-effects or fertilityClinic.com/services/egg-freezing-for-cancer-patients — reveals the health condition being researched, the treatment being considered, and the medical context the user is navigating.
Clarkson Law Firm’s CIPA Section 631 theory in healthcare cases argues that when Meta Pixel (or Google Analytics, or any other tracking tool) intercepts and transmits these health-specific URLs to a third party in real time — while the user is in the midst of their healthcare website visit — it constitutes an unauthorized interception of electronic communication whose content is inherently protected health information.
The “in transit” element of CIPA Section 631 is satisfied because the pixel captures and transmits data as the user navigates — not after the session is over, not from stored logs, but in real time as the communication occurs. The “third party” element is satisfied because Meta or Google is not the intended recipient of the user’s communication with the healthcare website — it is an unauthorized eavesdropper. The “without consent” element is satisfied because users visiting healthcare websites to schedule appointments or research medical conditions have not consented to simultaneous data transmission to social media advertising platforms.
What makes Clarkson’s application of this theory particularly difficult for healthcare defendants to defeat is the combination of technical specificity in the complaints — documenting exactly what URLs were transmitted, exactly which pixels transmitted them, and exactly how the transmitted data links to user identity — and the legal clarity of the healthcare context, where courts do not need to evaluate whether the intercepted information is “sensitive” in the abstract. In healthcare, it is inherently sensitive by definition.
ECPA: The Federal Wiretapping Dimension
The Electronic Communications Privacy Act is the federal counterpart to CIPA — enacted in 1986 to extend the Federal Wiretap Act’s protections to electronic communications. Its Title I (the Wiretap Act as amended) prohibits the intentional interception of any wire, oral, or electronic communication.
Clarkson Law Firm’s pursuit of ECPA claims in healthcare pixel cases alongside CIPA creates both a federal law foundation and a strategic litigation option — federal court can sometimes be a more favorable forum than California state court for certain procedural reasons, and the ECPA claim provides a basis for federal jurisdiction that the CIPA claim alone might not.
The ECPA analysis in the healthcare pixel context mirrors the CIPA analysis: the pixel intercepts electronic communications between the patient and the healthcare website in real time, the interception is intentional (the pixel is deliberately deployed to capture user behavior), and the pixel operator (Meta or Google) is a third party to the communication without consent from either party to receive the interception.
ECPA provides for civil remedies including the greater of actual damages or statutory damages of $10,000, plus punitive damages for willful violations, plus attorney’s fees. In the class action context, ECPA’s per-violation statutory damages structure creates aggregate exposure that — combined with CIPA’s $5,000 per violation and CMIA’s $1,000 per violation — produces a compounding damages model that makes healthcare pixel cases financially dangerous at scale.
The California Constitutional Privacy Right in Healthcare
As discussed in the Ahdoot & Wolfson analysis, California’s constitutional privacy right provides a cause of action that is evaluating the broader question of whether conduct violated patients’ reasonable privacy expectations — a standard that is more flexible and more difficult to defeat on technical grounds than statutory theories.
Clarkson Law Firm’s use of the constitutional privacy theory in healthcare cases reflects the public interest character of the firm’s litigation approach: the constitutional claim frames the case not as a technical statutory violation but as a fundamental rights issue — whether patients can reasonably expect that their medical appointments, health conditions, and treatment decisions will not be transmitted to social media companies without their knowledge.
This framing resonates with courts in a way that pure statutory analysis does not. The constitutional right to privacy is enshrined in California’s foundational legal document. When a healthcare organization’s tracking technology practices violate that right, the case is not merely about a failed HIPAA compliance step — it is about a failure to respect the constitutional dignity of patients.
The Healthcare Targets: Fertility Clinics, Patient Portals, and Beyond
Fertility Clinics: The Intersection of Maximum Sensitivity and Maximum Scrutiny
Clarkson Law Firm, like Ahdoot & Wolfson, has made fertility clinics a primary focus of its healthcare pixel practice. The reasons for this focus — the extreme sensitivity of reproductive health information, the specific legal protections that exist for reproductive data, the emotional resonance of the harm with courts and juries — are discussed in detail in the Ahdoot & Wolfson analysis.
What distinguishes Clarkson’s approach in the fertility clinic context is the explicit connection to the public interest framing. Reproductive health privacy is not merely a legal compliance issue for Clarkson — it is a social justice concern. The Dobbs decision’s elimination of constitutional abortion rights at the federal level created a political and legal landscape in which reproductive health data has become potentially dangerous in ways that extend beyond advertising — the transmission of abortion-related health research, fertility clinic visits, or pregnancy loss records to advertising platforms, where that data can be subpoenaed by law enforcement in states that have criminalized abortion, represents a category of harm that Clarkson’s public interest mission is specifically oriented to address.
The post-Dobbs reproductive privacy dimension is not a marginal legal consideration in Clarkson’s fertility clinic cases. It is a central element of why these cases matter beyond their technical privacy law significance. When a fertility clinic’s Meta Pixel transmits a patient’s reproductive health research to Facebook’s servers — servers that are subject to law enforcement subpoena — the privacy harm is not merely reputational or commercial. It may, in some circumstances, be a matter of personal safety.
Clarkson Law Firm’s willingness to frame its fertility clinic cases in these terms — connecting pixel tracking compliance to the broader landscape of reproductive rights and personal safety — is distinctive and amplifies the public pressure on defendants beyond what a purely technical privacy case would generate.
Patient Portals: The Core HIPAA-Covered Environment
Hospital and health system patient portals represent the clearest-cut case for tracking technology removal in the healthcare compliance landscape. These portals are explicitly HIPAA-covered environments where patients access their most sensitive health information — diagnoses, medication lists, test results, clinical notes, and communication with their care teams.
The deployment of advertising pixels on patient portal pages is, under HHS OCR’s guidance, a presumptive HIPAA violation. OCR has specifically identified authenticated user environments — where the user is logged into a portal — as contexts in which tracking technologies are particularly likely to transmit PHI because the user’s identity is established and linked to the health information being accessed.
Clarkson Law Firm’s patient portal cases make the legal argument at its most straightforward: the pixel was on a HIPAA-covered page, the user was an identified patient, the transmitted data was PHI, no BAA existed, therefore HIPAA was violated. The CIPA wiretapping theory layers on top of this structural HIPAA violation, creating the compound statutory exposure that makes these cases financially significant.
The patient portal target category is also distinctive because the harm is not merely theoretical or statistical. When a patient portal pixel transmits data, the patient is someone who has already established a care relationship with the healthcare provider — they have a treatment history, a medication list, a diagnosis that is documented in the system. The transmitted data is not behavioral inference but confirmed medical information about a known individual.
Telehealth Platforms and Health Information Websites
Clarkson Law Firm’s practice extends beyond traditional healthcare providers to telehealth platforms and health information websites — a category that includes some of the most widely used consumer health resources on the internet.
Health information websites — platforms that provide symptom checkers, condition information, medication guides, and health education content — occupy an interesting legal position. Many of them are not HIPAA covered entities (they do not provide healthcare services and do not have treatment relationships with users). But the information their users seek is inherently sensitive health information, and the users’ reasonable expectation that their health research is private is as strong as if they were consulting a physician.
Clarkson’s CIPA and constitutional privacy theories apply to these platforms even in the absence of HIPAA coverage — because CIPA and the California Constitutional right to privacy are not limited to healthcare providers. Any website that intercepts sensitive health-related browsing behavior and transmits it to third-party advertising platforms faces CIPA exposure, regardless of whether it is a HIPAA covered entity.
For telehealth platforms — which do have healthcare provider relationships and are HIPAA covered — the combination of HIPAA, CMIA, CIPA, ECPA, and constitutional privacy claims creates the same full-stack healthcare pixel liability that hospital pixel cases present.
The AI Frontier: Where Clarkson Is Going Next
Why AI in Healthcare Is the Next Privacy Litigation Wave
Clarkson Law Firm’s development of privacy claims around artificial intelligence and automated decision-making in healthcare is one of the most strategically important signals about where healthcare privacy litigation is heading. Understanding the emerging AI liability theories helps compliance teams get ahead of the next wave before litigation documents what they are doing wrong.
The AI healthcare privacy landscape encompasses several distinct categories of concern:
Patient data used to train AI models without adequate consent. Healthcare AI companies — and healthcare organizations developing their own AI tools — frequently train their models on patient data: clinical notes, diagnostic images, genomic data, treatment histories, and behavioral data from patient portals and health apps. In many cases, the patients whose data is used for AI training did not specifically consent to that use. HIPAA’s treatment-payment-operations exceptions may or may not cover AI training uses depending on the specific facts, and California’s CMIA requires authorization for uses of medical information beyond the primary treatment purpose.
AI diagnostic tools operating on health data without adequate consent disclosure. AI-powered diagnostic tools — symptom checkers, risk assessment algorithms, predictive models for disease progression — process patient health information through automated systems that may not be adequately disclosed to patients. Patients who interact with what appears to be a simple symptom information feature may not understand that their responses are being processed by an AI model that retains and learns from their health data.
Health applications collecting data beyond their stated purpose. Consumer health applications — fitness trackers, period tracking apps, mental health apps, nutrition apps — collect detailed behavioral and physiological data that is increasingly used for purposes beyond the primary app function: sold to data brokers, shared with advertising platforms, or used to train AI models. Clarkson’s consumer protection and privacy theories apply to these practices, particularly when the secondary data uses are not adequately disclosed.
AI-driven personalization in healthcare marketing. Healthcare organizations that use AI to personalize their marketing — targeting users with advertising based on AI-inferred health conditions — create a specific category of harm that combines the pixel tracking liability with AI profiling. If the AI inference is wrong, it attributes false health conditions to individuals. If it is right, it reveals sensitive health information the individual never disclosed.
The Consent Gap in Healthcare AI
The foundational compliance issue in healthcare AI — the one that Clarkson Law Firm’s AI claims are designed to exploit — is the consent gap: the systematic absence of specific, informed consent for AI-specific uses of health data, even from patients who have signed general HIPAA authorizations or clicked through health app terms of service.
HIPAA’s authorization requirements apply to disclosures of PHI for purposes other than treatment, payment, and healthcare operations. AI model training is not clearly within any of these exceptions unless the AI model is directly integral to the care delivery process. Selling patient data to AI companies, sharing clinical data with AI research partnerships, or using patient behavioral data to train commercial AI diagnostic products likely requires specific patient authorization that most healthcare AI practices have not obtained.
California’s Confidentiality of Medical Information Act has similar authorization requirements — and California’s proposed and enacted AI regulations add additional consent and transparency obligations for automated decision-making that uses personal information.
Clarkson Law Firm’s development of AI-specific privacy claims positions the firm to pursue the next generation of healthcare privacy violations as the current pixel tracking wave matures. For healthcare organizations and digital health companies investing in AI capabilities, the consent architecture for AI data use should be built now — before the litigation that punishes failing to build it arrives.
The Intersection of AI and Sensitive Health Categories
The AI liability risk is amplified in the healthcare categories that Clarkson already prioritizes: reproductive health, mental health, and genomic data. AI models trained on fertility clinic patient data, mental health treatment records, or genomic information raise the same emotional and legal dimensions as pixel tracking in these contexts — the sensitivity of the underlying data makes the absence of specific consent more egregious and more legally consequential.
An AI model trained on fertility clinic patient records to predict IVF success rates — without specific patient authorization — is precisely the kind of case that Clarkson’s public interest mission and healthcare privacy expertise position it to pursue. The legal theories (HIPAA authorization requirements, CMIA, potentially ECPA depending on data transmission methods) are available. The harm is real and documentable. The defendant is an institutional actor whose conduct falls within the firm’s core targeting profile.
The Investigation Model and Pre-Filing Surveillance
How Clarkson Identifies Targets Before Filing
Like Ahdoot & Wolfson and other technically sophisticated plaintiff privacy firms, Clarkson Law Firm’s case development begins with proactive technical investigation of potential defendants — documenting pixel configurations, capturing network traffic, and building the factual record before any complaint is filed.
The investigation process is systematic and methodical. Investigators visit target healthcare websites as ordinary users, document every third-party script and pixel deployed, analyze network traffic to identify what data those tools transmit, evaluate whether transmitted data constitutes PHI, assess consent mechanism configurations, and preserve the complete technical record as evidence.
Clarkson’s public interest framing adds a dimension to this investigation model that purely economic plaintiff firms do not have: the investigation is oriented toward finding defendants whose conduct represents the most consequential privacy violations, not merely the most legally straightforward ones. A fertility clinic that deployed Meta Pixel on IVF consultation booking pages is a more compelling target than a non-healthcare company with a similar pixel configuration — not because the legal theory is stronger, but because the harm is greater and the public interest in correcting it is higher.
The Regulatory Complaint Parallel
Alongside civil litigation, Clarkson Law Firm’s public interest orientation means the firm may also file or encourage regulatory complaints with HHS OCR, the California Privacy Protection Agency, and other enforcement bodies as part of a coordinated accountability strategy.
This regulatory-civil parallel is important for defendants to understand. A healthcare organization that receives a Clarkson class action complaint may simultaneously face an OCR complaint that triggers an investigation, a potential California AG inquiry, and media coverage connecting the civil litigation to the regulatory failure. Managing these parallel tracks requires a coordinated response that addresses the full compliance picture, not just the civil litigation in isolation.
The Compounding Liability Framework in Clarkson Cases
How HIPAA, CMIA, CIPA, ECPA, and Constitutional Privacy Stack
One of the defining features of Clarkson Law Firm’s healthcare privacy cases — shared with Ahdoot & Wolfson and Dovel & Luner — is the multi-theory complaint structure that creates compounding liability exposure across multiple independent legal frameworks simultaneously.
A California-based fertility clinic that deployed Meta Pixel on its website without adequate safeguards faces:
HIPAA regulatory exposure: OCR enforcement action, potential civil monetary penalties ranging from $100 to $50,000 per violation (with an annual cap of $1.9 million per violation category), and potentially mandatory corrective action plans. HIPAA does not provide a private right of action, so this exposure is regulatory rather than civil — but it runs parallel to and reinforces the civil litigation.
CMIA civil liability: $1,000 nominal damages per unauthorized disclosure of medical information, actual damages for proven harm, punitive damages for egregious conduct, and attorney’s fees under California’s private attorney general statute. For a fertility clinic with tens of thousands of website visitors during the class period, CMIA nominal damages alone can reach eight figures.
CIPA Section 631 civil liability: $5,000 per violation, representing each intercepted communication — potentially each user session or each pixel transmission event. Combined with CMIA, the per-affected-patient damages exposure can reach $6,000 before actual harm analysis.
ECPA civil liability: The greater of actual damages or $10,000 in statutory damages per violation, plus punitive damages for willful violations, plus attorney’s fees. ECPA’s higher per-violation statutory damages create additional damages exposure on top of the CIPA and CMIA amounts.
California Constitutional privacy: Damages for violation of a constitutional right, with a flexible standard that does not depend on statutory elements. May support additional damages above what the statutory frameworks provide.
UCL: Restitution of all money the defendant acquired through the unfair business practice (potentially including advertising revenue derived from pixel-transmitted patient data), injunctive relief, and attorney’s fees.
The aggregate exposure across all these theories — for a single fertility clinic with a multi-year pixel deployment affecting tens of thousands of patients — can reach nine figures in statutory damages alone. This is the financial reality that Clarkson Law Firm’s multi-theory complaints create, and it is the reality that healthcare defendants need to internalize when assessing the urgency of compliance remediation.
Why Multi-Theory Complaints Are Difficult to Dismiss
Multi-theory complaints are strategically superior to single-theory complaints for a specific procedural reason: if some theories are dismissed at the pleading stage, others survive, and the case continues. A defendant that successfully moves to dismiss ECPA claims on technical grounds still faces CIPA, CMIA, and constitutional claims. A defendant that defeats the constitutional privacy theory on standing grounds still faces the statutory claims.
Each theory that survives a motion to dismiss is a basis for discovery, for class certification, and for settlement pressure. The multi-theory approach means that achieving complete dismissal requires defeating every theory simultaneously — a substantially higher bar than defeating any single theory.
Clarkson’s complaints are drafted with this procedural reality in mind. The legal theories are not merely piled on for appearance — each is supported by specific factual allegations and legal arguments designed to survive independent challenge. This drafting approach makes early dismissal less likely and sustained litigation more probable.
Compliance Priorities: What Clarkson’s Cases Demand
The Non-Negotiable: No Advertising Pixels on HIPAA-Covered Pages
The foundational compliance principle that emerges from Clarkson Law Firm’s cases — as from every other healthcare pixel plaintiff firm’s cases — is absolute: advertising pixels from platforms without BAAs do not belong on HIPAA-covered pages.
For fertility clinics, this means every page related to reproductive health services, IVF procedures, fertility diagnoses, and appointment scheduling. For hospitals, it means every patient portal page, appointment scheduling page, condition information page, and test result access page. For telehealth platforms, it means the entire patient-facing application interface.
The presence of a cookie consent banner does not change this analysis. Consent is not a substitute for a BAA. A patient who clicks “Accept All Cookies” has not signed a HIPAA authorization for the transmission of their PHI to Meta or Google. The BAA requirement cannot be waived by patient consent — it is an obligation between the covered entity and the business associate that protects the healthcare system’s integrity independent of individual patient preferences.
The AI Data Governance Imperative
For healthcare organizations and digital health companies engaged in AI development or deployment, Clarkson Law Firm’s emerging AI practice creates a specific compliance imperative: build consent architecture for AI data uses now.
This means:
Auditing current AI data use practices. What patient data is used to train AI models? What AI systems process patient health information? What disclosures exist regarding these uses? What consents or authorizations have been obtained?
Assessing whether current authorizations cover AI data uses. HIPAA’s treatment-payment-operations exceptions are narrow. AI model training on patient data for commercial purposes likely requires specific authorization. Review whether the consents and authorizations your organization has obtained specifically cover AI uses.
Updating consent and authorization documentation. If consent documents do not specifically address AI training, AI-driven personalization, or AI diagnostic tools, update them to include specific, plain-language disclosure of these uses.
Implementing data governance for AI systems. Who reviews AI data use decisions? How are new AI data uses assessed for HIPAA and CMIA compliance? Is privacy counsel involved in AI product development decisions? Build governance infrastructure now rather than after litigation documents the absence of it.
The Change Management Gap
One of the most common and most legally consequential compliance failures in the healthcare pixel space — and one that Clarkson Law Firm’s investigations systematically expose — is the absence of change management controls for website technology.
Healthcare marketing teams add tags, pixels, and scripts to websites constantly — in response to new campaign strategies, new analytics tools, new advertising partnerships. Each addition is a potential compliance event. Without a process that requires privacy review before new third-party scripts are deployed on patient-facing pages, each new marketing technology decision is also a potential CIPA, HIPAA, and CMIA exposure decision made without legal input.
The compliance fix is organizational as much as technical: establish a policy requiring privacy and legal review before any new third-party tag or script is added to patient-facing pages. This review should assess whether the tool creates BAA obligations, whether the data it collects or transmits constitutes PHI, and whether adequate consent mechanisms are in place. Document the review process and its outcomes for each technology decision.
This change management infrastructure is not technically demanding or expensive. But its absence is consistently what creates the multi-year class periods — the gaps between when a pixel was deployed, when marketing realized it was non-compliant, and when legal remediated it — that define the scope of healthcare pixel class actions.
Frequently Asked Questions About Clarkson Law Firm Healthcare Privacy Litigation
What distinguishes Clarkson Law Firm from other healthcare pixel plaintiff firms?
The explicit public interest mission and the AI practice development are the most distinctive elements. Clarkson is not primarily optimizing for settlement volume — it is pursuing cases that drive systemic change in how healthcare organizations handle patient data. This orientation produces a litigation approach that emphasizes injunctive and behavioral relief alongside monetary recovery, and that looks beyond the current pixel tracking litigation wave to the next frontier: AI data use in healthcare.
Is ECPA redundant with CIPA in healthcare pixel cases?
Not entirely. ECPA provides federal jurisdiction that CIPA does not, enabling federal court filing when that forum is strategically preferable. ECPA’s statutory damages ($10,000 per violation) are higher than CIPA’s ($5,000 per violation), creating additional damages exposure. And ECPA’s coverage of conduct by out-of-state defendants who may not be reachable under California state law provides coverage for cases where the defendant is not California-based.
Does the public interest framing affect how Clarkson negotiates settlements?
Yes. Clarkson’s settlements typically include more emphasis on injunctive relief — specific commitments to remediate tracking configurations, implement compliance processes, and submit to monitoring — than purely economic plaintiff firms. For defendants, this means settlements with Clarkson are not simply financial transactions. They are compliance commitments that may require ongoing implementation and potentially reporting.
What is the emerging AI healthcare privacy claim that Clarkson is developing?
The core theory is that healthcare organizations and digital health companies using patient data to train AI models, power AI diagnostic tools, or enable AI-driven personalization have done so without the specific consent or authorization that HIPAA, CMIA, and California privacy law require. The claims build on the same consent-gap analysis underlying the pixel cases — the gap between what patients understood they were authorizing and what was actually done with their data — applied to AI data use rather than advertising pixel data sharing.
What should a fertility clinic do upon receiving a Clarkson Law Firm investigation notice or complaint?
Retain HIPAA and privacy litigation counsel immediately. Preserve all documentation of website configurations and pixel deployments. Assess whether the pixel operation constitutes a reportable HIPAA breach requiring OCR notification. Conduct an internal technical audit of current configurations under legal privilege. Evaluate remediation options in consultation with counsel before making any changes to the website. Do not issue public statements about the litigation without legal guidance.
Does the reproductive privacy dimension of Clarkson’s fertility clinic cases create exposure beyond traditional HIPAA analysis?
Yes. Post-Dobbs state reproductive privacy laws — including California’s SB 934 — provide additional protections for reproductive health information that supplement HIPAA and CMIA. These laws may prohibit disclosures of reproductive health data even in contexts where HIPAA’s exceptions might otherwise permit them, and they may create independent civil liability beyond what the federal framework provides.
The Firm That Connects Healthcare Pixels to a Larger Vision of Patient Rights
Clarkson Law Firm, P.C. occupies a distinctive position in the healthcare privacy litigation landscape. Where Dovel & Luner brings trial-oriented ferocity and Ahdoot & Wolfson brings CMIA-specific technical depth, Clarkson brings a public interest framework that connects healthcare pixel compliance to broader questions about patient dignity, reproductive rights, and the appropriate limits of surveillance in the most intimate contexts of human experience.
For compliance professionals, the public interest framing is not merely philosophical packaging around standard plaintiff litigation. It reflects a genuine strategic orientation that produces cases designed to drive systemic change — and that will continue producing such cases as the technology landscape evolves. The current focus on Meta Pixel and advertising pixels will mature into AI data use claims, automated decision-making challenges, and the next category of healthcare technology practice that creates a gap between what patients reasonably expect and what healthcare digital infrastructure actually does.
The compliance posture that addresses Clarkson Law Firm’s current practice — remove advertising pixels from patient-facing pages, implement BAA-compliant analytics configurations, document remediation, build change management controls — is the same posture that prepares for the AI privacy claims coming next: specific consent for AI data uses, transparent disclosure of automated processing, governance infrastructure that requires privacy review of AI product decisions before deployment.
Every healthcare organization that handles patient data through digital systems is, in some sense, engaged in an ongoing negotiation between the capabilities of digital technology and the privacy rights of patients. Clarkson Law Firm exists to enforce the terms of that negotiation — on behalf of the patients who cannot enforce it themselves.
How to Protect Against a Clarkson Privacy Lawsuit?
If you’ve received a notice or a demand letter about a privacy violation it would be a great time to get your site compliant and avoid the other 50 law firms on the trail of Clarkson that are filing these privacy claims for wiretrapping and other alleged violations. The team at Captain Compliance can get your site fixed and help avoid future privacy claims. Book a demo below to get protected today.
